Market Overview:
The global liposomal market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for liposomes in various applications such as skin care, hair care, and others. In addition, the growing awareness about the benefits of using liposomes is also contributing to the growth of this market. The global liposomal market by type is segmented into Liposome Vitamin, Liposome Ceramide, Liposome CoQ10 and Other types. The Liposome Vitamin segment accounted for a major share of the global liposomal market in 2017 and is projected to grow at a CAGR of 7% during the forecast period from 2018 to 2030.
Product Definition:
A liposome is a small vesicle composed of lipid bilayers. It is a simple way to encapsulate drugs, making them more resistant to degradation and thus increasing their bioavailability.
Liposome Vitamin:
Liposome vitamins are liposomes that contain vitamin-like substances. They can be used as nutraceuticals or pharmaceuticals depending on the method of administration and target cell type. The most commonly used liposome vitamins are Vitamin C, Vitamin D, and Vitamin E.
Liposome Ceramide:
Liposome is a lipoprotein complex, which is composed of phospholipids and proteins. It helps in increasing the surface area of the cell and allows it to act as an efficient carrier for drugs. Ceramide (4-hydroxy-3-methoxylate) is one such drug that finds its application in liposomes.
Application Insights:
The skin care segment dominated the global market in 2017. The product is used for treating various skin conditions, such as acne, aging lines & wrinkles and eczema. It helps improve the appearance of scars by enhancing their fading effect. In addition, it also helps reduce pore size and enhance skin elasticity.
The hair care application segment is expected to witness significant growth over the forecast period owing to increasing consumer awareness regarding healthy hair growth and maintenance practices coupled with rising demand for cosmetic products that help improve hair quality & texture. These factors are likely to drive demand in this segment over the coming years.
Other applications include cosmetics (face cream) and personal care (body lotion).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to increasing R&D activities and rising product demand for use in nutraceuticals, pharmaceuticals, and cosmetics applications. Europe accounted for a significant share of revenue due to growing consumer awareness regarding bio-based products along with stringent regulations on synthetic chemicals in the region. Asia Pacific is projected to be one of the fastest-growing regions over the forecast period owing to high unmet clinical needs coupled with rapidly expanding medical tourism industry.
Major players operating in this space include Lipsos (U.K.), CELGENE CORP.(U S A), AVON Product Inc (USA) LipoGen Ltd.(Israel). These companies are engaged in various strategic initiatives such as expansion of distribution networks, mergers & acquisitions etc.
Growth Factors:
- Increasing demand for minimally invasive and non-invasive cosmetic procedures
- Rising prevalence of obesity and other lifestyle diseases
- Growing awareness about the benefits of liposomal technology
- Technological advancements in liposomal products and delivery systems
- Rising demand from emerging markets
Scope Of The Report
Report Attributes
Report Details
Report Title
Liposomal Market Research Report
By Type
Liposome Vitamin, Liposome Ceramide, Liposome CoQ10, Other
By Application
Skin Care, Hair Care
By Companies
Lipoid Kosmetik, Lucas Meyer Cosmetics, Nippon Fine Chemical, Enoc Pharma, Nanovec, Lipotec, Croda, H&A Pharmachem, Lipomize, ID bio, BioSpectrum, Derma Clinical, Kewpie Corporation, Nanohealth Biotech, Creative Biostructure, Phenbiox
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Liposomal Market Report Segments:
The global Liposomal market is segmented on the basis of:
Types
Liposome Vitamin, Liposome Ceramide, Liposome CoQ10, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Skin Care, Hair Care
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lipoid Kosmetik
- Lucas Meyer Cosmetics
- Nippon Fine Chemical
- Enoc Pharma
- Nanovec
- Lipotec
- Croda
- H&A Pharmachem
- Lipomize
- ID bio
- BioSpectrum
- Derma Clinical
- Kewpie Corporation
- Nanohealth Biotech
- Creative Biostructure
- Phenbiox
Highlights of The Liposomal Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liposome Vitamin
- Liposome Ceramide
- Liposome CoQ10
- Other
- By Application:
- Skin Care
- Hair Care
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Liposomal Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A liposomal is a type of delivery system that uses small, self-contained vesicles to carry drugs or other substances. Liposomes are made up of phospholipids and water, and they are often used to deliver medications directly to the target area.
Some of the major companies in the liposomal market are Lipoid Kosmetik, Lucas Meyer Cosmetics, Nippon Fine Chemical, Enoc Pharma, Nanovec, Lipotec, Croda, H&A Pharmachem, Lipomize, ID bio, BioSpectrum, Derma Clinical, Kewpie Corporation, Nanohealth Biotech, Creative Biostructure, Phenbiox.
The liposomal market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Liposomal Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Liposomal Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Liposomal Market - Supply Chain
4.5. Global Liposomal Market Forecast
4.5.1. Liposomal Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Liposomal Market Size (000 Units) and Y-o-Y Growth
4.5.3. Liposomal Market Absolute $ Opportunity
5. Global Liposomal Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Liposomal Market Size and Volume Forecast by Type
5.3.1. Liposome Vitamin
5.3.2. Liposome Ceramide
5.3.3. Liposome CoQ10
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Liposomal Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Liposomal Market Size and Volume Forecast by Application
6.3.1. Skin Care
6.3.2. Hair Care
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Liposomal Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Liposomal Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Liposomal Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Liposomal Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Liposomal Demand Share Forecast, 2019-2026
9. North America Liposomal Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Liposomal Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Liposomal Market Size and Volume Forecast by Application
9.4.1. Skin Care
9.4.2. Hair Care
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Liposomal Market Size and Volume Forecast by Type
9.7.1. Liposome Vitamin
9.7.2. Liposome Ceramide
9.7.3. Liposome CoQ10
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Liposomal Demand Share Forecast, 2019-2026
10. Latin America Liposomal Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Liposomal Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Liposomal Market Size and Volume Forecast by Application
10.4.1. Skin Care
10.4.2. Hair Care
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Liposomal Market Size and Volume Forecast by Type
10.7.1. Liposome Vitamin
10.7.2. Liposome Ceramide
10.7.3. Liposome CoQ10
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Liposomal Demand Share Forecast, 2019-2026
11. Europe Liposomal Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Liposomal Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Liposomal Market Size and Volume Forecast by Application
11.4.1. Skin Care
11.4.2. Hair Care
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Liposomal Market Size and Volume Forecast by Type
11.7.1. Liposome Vitamin
11.7.2. Liposome Ceramide
11.7.3. Liposome CoQ10
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Liposomal Demand Share, 2019-2026
12. Asia Pacific Liposomal Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Liposomal Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Liposomal Market Size and Volume Forecast by Application
12.4.1. Skin Care
12.4.2. Hair Care
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Liposomal Market Size and Volume Forecast by Type
12.7.1. Liposome Vitamin
12.7.2. Liposome Ceramide
12.7.3. Liposome CoQ10
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Liposomal Demand Share, 2019-2026
13. Middle East & Africa Liposomal Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Liposomal Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Liposomal Market Size and Volume Forecast by Application
13.4.1. Skin Care
13.4.2. Hair Care
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Liposomal Market Size and Volume Forecast by Type
13.7.1. Liposome Vitamin
13.7.2. Liposome Ceramide
13.7.3. Liposome CoQ10
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Liposomal Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Liposomal Market: Market Share Analysis
14.2. Liposomal Distributors and Customers
14.3. Liposomal Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Lipoid Kosmetik
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Lucas Meyer Cosmetics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Nippon Fine Chemical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Enoc Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Nanovec
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Lipotec
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Croda
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. H&A Pharmachem
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Lipomize
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. ID bio
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. BioSpectrum
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Derma Clinical
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Kewpie Corporation
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Nanohealth Biotech
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Creative Biostructure
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Phenbiox
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
